Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemorrhage × Dalteparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thromboembolism 11 Venous Thrombosis 8 Pulmonary Embolism 8 Neoplasms 8 Thrombosis 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lung Neoplasms 3 Thromboembolism 2 Neoplasm Metastasis 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Tranexamic Acid 11 Sodium Chloride 4 Saline Solution 3 Misoprostol 3 carbetocin 2 Tourniquets 2 Endoscopic Mucosal Resection 2 Vitamin B 6 1 Vasopressins 1 Uterine Artery Embolization 1 Ultrasonography 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Sutures 1 Surveys and Questionnaires 1 Surgicel 1 Standard of Care 1 Solutions 1 Sensitivity Training Groups 1 Rivaroxaban 1 Ringer's Lactate 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Palliative Care 1 Oxytocin 1 Neuromuscular Blockade 1 N(4)-oleylcytosine arabinoside 1 Methylergonovine 1 Mannitol 1 Injections, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01741506 2015-06-23

COPPVATS

Aarhus University Hospital

Phase 4 Completed

Hemorrhage, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡